About the Editors


Mohit Kumar Jolly, PhD
Indian Institute of Science
Bengaluru, India


Dr. Jolly leads the Cancer Systems Biology group at Indian Institute of Science, Bangalore. His research focus is on decoding the underlying design principles of various cell-fate decision networks as well elucidating the emergent dynamics of phenotypic plasticity and non-genetic heterogeneity in multiple biological contexts – cellular differentiation and reprogramming, cancer metastasis and resistance against many therapies.

Managing Editor

Nico Fanget, PhD


Nico obtained his PhD in bacteriology and molecular biology at Edinburgh Napier University. He then moved to scholarly publishing, first as staff editor at the Microbiology Society, then as copy editor at Nature. Nico joined the Nature partner Journals in 2016, and now manages four npj series titles.

He is based in London.

Associate Editors

Reka Albert, PhD
Distinguished Professor of Physics and Biology 
Pennsylvania State University

Prof. Albert's research has two main thrusts: collaborating with experimental groups to develop predictive dynamic models of biological systems at various levels of organization and developing network-based dynamical methodologies to drive biological systems to beneficial attractors (phenotypes).

Velia SicilianoVelia Siciliano, PhD
Principal Investigator
Istituto Italiano di Tecnologia-IIT
Naples, Italy

Dr.  Siciliano is Principal Investigator at Istituto Italiano di Tecnologia-IIT. She established the Synthetic and Systems Biology Lab for Biomedicine. She is also honorary fellow of Imperial College London where she still supervises research activities. Velia’s research focus is on designing and prototyping new therapeutic approaches based on non-invasive modification of mammalian cells with a specific focus on T cells. Her work also encompasses the use of DNA or RNA circuits to study biological processes.

Jun Seita, MD, PhD
Team Leader
RIKEN Medical Sciences Innovation Hub Program
Tokyo, Japan


Jun Seita is a Team Leader at the RIKEN Medical Sciences Innovation Hub Program. His team has been studying deep learning on health and medical data, and systems approach for developmental and stem cell biology at a single cell resolution.

Founding Editor-in-Chief

Hiroaki Kitano, PhD
President, Systems Biology Institute and Sony Computer Science Laboratories, Inc
Tokyo, Japan

Hiroaki Kitano is the President of the SBI; he is also President & CEO of Sony Computer Science Laboratories, Inc, Principal Investigator of the Okinawa Institute of Science and Technology Graduate University (OIST) and Group Director at the RIKEN Center for Integrative Medical Sciences. He is an expert in the fields of artificial intelligence and bioinformatics and is a leading figure in the emerging field of gene network modeling.  

Editorial Board Members

Joel Bader, PhD, Johns Hopkins University, Maryland, USA 
Matteo Barberis, PhD, University of Surrey, Surrey, UK
Luonan Chen, PhD, Chinese Academy of Sciences, Shanghai, China
James Collins, PhD, Massachusetts Institute of Technology, Massachusetts, USA
Edmund J. Crampin, PhD, University of Melbourne, Melbourne, Australia
Frank Doyle, PhD, Harvard University, Massachusetts, USA
Roland Eils, PhD, German Cancer Research Center, Heidelberg, Germany
Adriano Henney, PhD, Avicenna Alliance for Predictive Medicine, Cheshire, UK
Leroy Hood, PhD, Institute for Systems Biology, Washington, USA
Peter Hunter, PhD, University of Auckland, Auckland, NZ
Ravi Iyengar, PhD, Icahn School of Medicine, New York, USA
Ursula Klingmüller, PhD, German Cancer Research Center, Heidelberg, Germany
Edda Klipp, PhD, Humboldt-Universität zu Berlin, Berlin, Germany
Shinya Kuroda, PhD, University of Tokyo, Tokyo, Japan
Xin Lai, PhD, BioMediTech, Tampere University, Tampere, Finland
Mariko Okada, PhD, Osaka University, Osaka, Japan
Gibin Powathil, PhD, Swansea University, Swansea, UK
Stephen Quake, PhD, Standford University, California, USA
Padmini Rangamani, PhD, University of California San Diego, CA, USA
Nadia Rosenthal, PhD, Jackson Laboratory, Maine, USA
Uwe Sauer, PhD, ETH Zurich, Zurich, Switzerland
Birgit Schoeberl, PhD, Merrimack Pharmaceuticals, Massachusetts, USA
Michael Snyder, PhD, Stanford University, California, USA
Jӧrg Stelling, PhD, ETH Zurich, Zurich, Switzerland
John Tyson, PhD, Virginia Tech, Virginia, USA
Hiroko Ueda, PhD, University of Tokyo, Tokyo, Japan
Marc Vidal, PhD, Harvard University, Massachusetts, USA
Hans Westerhoff, PhD, University of Amsterdam, Amsterdam, Netherlands
Ioannis Xenarios, PhD, Swiss Institute of Bioinformatics, Lausanne, Switzerland


Interested in joining the journal team?

If you are interested in joining the journal as an Editorial Board Member or Associate Editor, please complete this Google form. Associate Editors are part of the editorial team that handle manuscripts, while Editorial Board Members are regular reviewers and are consulted for ad hoc advice. We will contact you if your expertise meets the needs of the journal.

Nature Portfolio journals are committed to promoting practices that support diversity, equity and inclusion in science communication and publishing, and we strongly encourage gender, race, ethnic, geographic, career stage and other diversity in our journal teams. Our in-house staff will use your information only for the purposes of identifying new editorial team or board members. Please contact the journal by email if you would like to remove your information from these records.

Please note that we are not able to respond to all applicants.